Anna Zhou

1.1k total citations
26 papers, 873 citations indexed

About

Anna Zhou is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Anna Zhou has authored 26 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Surgery. Recurrent topics in Anna Zhou's work include Acute Lymphoblastic Leukemia research (4 papers), Prostate Cancer Treatment and Research (4 papers) and Advanced Breast Cancer Therapies (3 papers). Anna Zhou is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Prostate Cancer Treatment and Research (4 papers) and Advanced Breast Cancer Therapies (3 papers). Anna Zhou collaborates with scholars based in United States, China and Canada. Anna Zhou's co-authors include Barry Bluestein, Gary W. Caldwell, Frank Larsen, Prakash C Tewari, Stephanie Chen, Benjamin Emmanuel, Debomita Sengupta, Ben Berkhout, Robert H. Silverman and Anne Gatignol and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Annals of Oncology.

In The Last Decade

Anna Zhou

22 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Zhou United States	9	378	248	182	159	86	26	873
Jianping Yang New Zealand	20	256 0.7×	822 3.3×	110 0.6×	403 2.5×	40 0.5×	44	1.1k
Justin P. Hart United States	10	233 0.6×	492 2.0×	140 0.8×	76 0.5×	25 0.3×	18	933
Shujuan Jiang China	16	359 0.9×	579 2.3×	269 1.5×	569 3.6×	18 0.2×	42	1.4k
Tong‐Min Wang China	15	253 0.7×	266 1.1×	82 0.5×	167 1.1×	69 0.8×	45	809
Hsin‐Pai Li Taiwan	15	409 1.1×	156 0.6×	77 0.4×	295 1.9×	67 0.8×	29	943
Sara Bass United States	14	206 0.5×	226 0.9×	81 0.4×	89 0.6×	60 0.7×	21	800
Karen Brajão de Oliveira Brazil	16	233 0.6×	310 1.3×	51 0.3×	296 1.9×	11 0.1×	63	740
Maggie Cam United States	18	395 1.0×	239 1.0×	63 0.3×	287 1.8×	9 0.1×	37	1.1k
Bruce Merchant United States	17	315 0.8×	416 1.7×	87 0.5×	245 1.5×	10 0.1×	55	993
Shunkichi Hiraki Japan	17	226 0.6×	316 1.3×	565 3.1×	534 3.4×	30 0.3×	72	1.3k

Countries citing papers authored by Anna Zhou

Since Specialization

Citations

This map shows the geographic impact of Anna Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Zhou more than expected).

Fields of papers citing papers by Anna Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Zhou. The network helps show where Anna Zhou may publish in the future.

Co-authorship network of co-authors of Anna Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Zhou. A scholar is included among the top collaborators of Anna Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Zhou. Anna Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lubeck, David, et al.. (2025). Costs of treating cataract surgery complications from a US provider perspective: a micro-costing approach for health economic analyses. Expert Review of Ophthalmology. 20(2). 67–78. 1 indexed citations

Zhou, Anna, et al.. (2025). Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy. Journal of Comparative Effectiveness Research. 14(3). e240208–e240208.

Siddiqi, Zaeem A., et al.. (2024). D.2 Cost-effectiveness analysis of efgartigimod vs chronic IVIg for treatment of patients with generalized myasthenia gravis in Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51(s1). S9–S9.

Zhou, Anna, Damaris Kuhnell, Benjamin H. Hinrichs, et al.. (2024). Multimodal assessment of high-risk human papillomavirus in sinonasal squamous cell carcinoma. Pathology - Research and Practice. 261. 155486–155486.

Mitchell, Ellen Siobhan, Annabell Suh Ho, Christine N. May, et al.. (2023). The Impact of a Digital Weight Loss Intervention on Health Care Resource Utilization and Costs Compared Between Users and Nonusers With Overweight and Obesity: Retrospective Analysis Study. JMIR mhealth and uhealth. 11. e47473–e47473. 4 indexed citations

Zhao, Melody, et al.. (2023). Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review. Targeted Oncology. 18(3). 327–358. 7 indexed citations

Morgans, Alicia K., Thomas E. Hutson, Alice Guan, et al.. (2022). An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective. BMC Health Services Research. 22(1). 916–916. 1 indexed citations

Harbeck, Nadia, Dean Spurden, Lin Zhan, et al.. (2021). CDK4/6 Inhibitors in HR+/HER2- Advanced/metastatic Breast Cancer: A Systematic Literature Review of Real-World Evidence Studies. Future Oncology. 17(16). 2107–2122. 51 indexed citations

Morgans, Alicia K., Thomas E. Hutson, Alice Guan, et al.. (2021). 587P Clinical and cost impact of cabazitaxel versus (vs) a second androgen receptor targeted agent (ARTA) for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel and the alternative ARTA (abiraterone or enzalutamide). Annals of Oncology. 32. S636–S637. 1 indexed citations

10.

Zhou, Anna, Jie Qu, Min Liu, & Patrick Tso. (2020). The Role of Interstitial Matrix and the Lymphatic System in Gastrointestinal Lipid and Lipoprotein Metabolism. Frontiers in Physiology. 11. 4–4. 20 indexed citations

11.

Spurden, Dean, et al.. (2020). PCN28 CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) IN HORMONE RECEPTOR-POSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC): A SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE (RWE) STUDIES. Value in Health. 23. S27–S27. 1 indexed citations

12.

Chen, Stephanie, et al.. (2020). Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis. Current Medical Research and Opinion. 36(11). 1913–1926. 25 indexed citations

13.

Conter, Henry Jacob, Scott Owen, Anna Zhou, et al.. (2019). Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC). Journal of Medical Economics. 22(7). 625–637. 25 indexed citations

14.

Mei, Shenghui, Xindi Li, Xiaoqing Gong, et al.. (2017). Comparison of 6‐mercaptopurine with 6‐thioguanine for the analysis of thiopurine S‐methyltransferase activity in human erythrocyte by LC–MS/MS. Biomedical Chromatography. 31(9). 5 indexed citations

15.

Li, Xindi, Shenghui Mei, Xiaoqing Gong, et al.. (2017). Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disorders. BMC Neurology. 17(1). 130–130. 5 indexed citations

16.

Gong, Xiaoqing, Shenghui Mei, Xindi Li, et al.. (2017). Association between TPMT*3C and decreased thiopurine S-methyltransferase activity in patients with neuromyelitis optica spectrum disorders in China. International Journal of Neuroscience. 128(6). 549–553. 2 indexed citations

17.

Liu, Yonghong, Huabing Wang, Xiaoqing Gong, et al.. (2016). Atypical MRI features in familial adult onset Alexander disease: case report. BMC Neurology. 16(1). 211–211. 6 indexed citations

18.

Mei, Shenghui, Xindi Li, Xiaoqing Gong, et al.. (2016). LC-MS/MS Analysis of Erythrocyte Thiopurine Nucleotides and Their Association With Genetic Variants in Patients With Neuromyelitis Optica Spectrum Disorders Taking Azathioprine. Therapeutic Drug Monitoring. 39(1). 5–12. 11 indexed citations

19.

Wang, Huabing, Anna Zhou, Lin Zhao, et al.. (2016). Good recovery of a patient with neurocysticercosis using two antihelminthic drugs combined with steroid. Neuroimmunology and Neuroinflammation. 3(5). 120–120.

20.

Zhou, Anna. (1993). Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell. 72(5). 753–765. 434 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact